By Natalie Rahhal Deputy Health Editor For Dailymail.com
Published: 18:09 GMT, 19 February 2019 | Updated: 18:09 GMT, 19 February 2019
View
comments
The US Food and Drug Administration (FDA) is warning against getting the 'young blood' transfusions that have become a hot topic in experimental treatments to block aging and Alzheimer's disease.
A number of recent studies on both animals and humans have suggested that compounds in younger people's blood may help treat conditions of old age, including Parkinson's and aging itself.
Some clinics offering the controversial transfusions have cropped up already in the US and abroad.
But the FDA warned today that there are no proven - much less approved - benefits of younger donor blood, and that the procedure's safety has not been established.
Some clinics across the US are already offering the transfusions of young blood plasma (pictured, whole blood) with unproven promises to treat aging. The FDA calls them 'bad actors'
A handful of experiments, studies and his own
